NDAIRRIGATIONSOLUTION
Approved
Jun 1959
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
BETAPRONE (propiolactone) by Forest Devices is antibodies. Approved for rabies in all age groups. First approved in 1959.
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
BETAPRONE (propiolactone) is an irrigation solution approved in 1959 for rabies treatment across all age groups. The drug works through an antibody-based mechanism of action delivered via topical irrigation. It represents a legacy therapeutic approach to rabies management.
LOE Approaching
Legacy product with LOE approaching; expect minimal commercial team expansion and focus on transition planning or product discontinuation.
Mechanism of Action
antibodies.
Indications (1)
Career Relevance
Zero linked job openings and approaching LOE indicate minimal hiring momentum and limited career growth runway on this product. Professionals assigned to BETAPRONE should anticipate transition planning, portfolio rationalization discussions, or redeployment to growing assets.
Brand Manager
Worked on BETAPRONE at Forest Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.